Quark patent anti-ENDO 180 (anti-MRC2/CD280)

抗体

MRC2抗体 | MRC2单克隆抗体 | MRC2药靶抗体 | ENDO 180药靶抗体 | ENDO 180单克隆抗体 | ENDO 180抗体 | CD280药靶抗体 | CD280单克隆抗体 | CD280抗体

C-type lectin domain family 13 member E antibody | C-type mannose receptor 2 antibody | CD 280 antibody | CD280 antibody | CD280 antigen antibody | CLEC 13E antibody | CLEC13E antibody | ENDO 180 antibody | ENDO180 antibody | Endocytic receptor (macrophag

Ab209804-100μg

100μg

无动物源

≥95%(SDS-PAGE&SEC-HPLC)

-80℃储存,避免反复冻融

超低温冰袋运输

Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.

Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0

No

May play a role as endocytotic lectin receptor displaying calcium-dependent lectin activity. Internalizes glycosylated ligands from the extracellular space for release in an endosomal compartment via clathrin-mediated endocytosis. May be involved in plasminogen activation system controlling the extracellular level of PLAUR/PLAU, and thus may regulate protease activity at the cell surface. May contribute to cellular uptake, remodeling and degradation of extracellular collagen matrices. May play a role during cancer progression as well as in other chronic tissue destructive diseases acting on collagen turnover. May participate in remodeling of extracellular matrix co-operating with the matrix metalloproteinases (MMPs).

人(Human)

人(Human)

MRC2

145.42 kDa

Unconjugated

Human IgG1

重组抗体

lambda

Protein A purified

Whole IgG